| 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of … F Mach, C Baigent, AL Catapano, KC Koskinas, M Casula, L Badimon, ... European heart journal 41 (1), 111-188, 2020 | 8723 | 2020 |
| 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with … FLJ Visseren, F Mach, YM Smulders, D Carballo, KC Koskinas, M Bäck, ... European heart journal 42 (34), 3227-3337, 2021 | 4556 | 2021 |
| 2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the European Society of … A Vahanian, F Beyersdorf, F Praz, M Milojevic, S Baldus, J Bauersachs, ... European heart journal 43 (7), 561-632, 2022 | 4215 | 2022 |
| 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the … M Humbert, G Kovacs, MM Hoeper, R Badagliacca, RMF Berger, M Brida, ... European heart journal 43 (38), 3618-3731, 2022 | 2462 | 2022 |
| 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European … M Glikson, JC Nielsen, MB Kronborg, Y Michowitz, A Auricchio, ... EP Europace 24 (1), 71-164, 2022 | 1726 | 2022 |
| 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology … AR Lyon, T Lopez-Fernandez, LS Couch, R Asteggiano, MC Aznar, ... European Heart Journal-Cardiovascular Imaging 23 (10), e333-e465, 2022 | 1357 | 2022 |
| 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Developed by the task force for the management of … K Zeppenfeld, J Tfelt-Hansen, M De Riva, BG Winkel, ER Behr, NA Blom, ... European heart journal 43 (40), 3997-4126, 2022 | 1311 | 2022 |
| Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous … L Räber, GS Mintz, KC Koskinas, TW Johnson, NR Holm, Y Onuma, ... European heart journal 39 (35), 3281-3300, 2018 | 690 | 2018 |
| 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment … TA McDonagh, M Metra, M Adamo, RS Gardner, A Baumbach, M Böhm, ... European Heart Journal 44 (37), 3627-3639, 2023 | 575 | 2023 |
| 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery: Developed by the task force for cardiovascular assessment and … S Halvorsen, J Mehilli, S Cassese, TS Hall, M Abdelhamid, E Barbato, ... European heart journal 43 (39), 3826-3924, 2022 | 529 | 2022 |
| ESC National Cardiac Societies; ESC Scientific Document Group. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice FLJ Visseren, F Mach, YM Smulders, D Carballo, KC Koskinas, M Bäck, ... Eur Heart J 42 (34), 3227-3337, 2021 | 445 | 2021 |
| Role of endothelial shear stress in stent restenosis and thrombosis: pathophysiologic mechanisms and implications for clinical translation KC Koskinas, YS Chatzizisis, AP Antoniadis, GD Giannoglou Journal of the American College of Cardiology 59 (15), 1337-1349, 2012 | 373 | 2012 |
| 2023 ESC Guidelines for the management of endocarditis: Developed by the task force on the management of endocarditis of the European Society of Cardiology (ESC) Endorsed by … V Delgado, N Ajmone Marsan, S de Waha, N Bonaros, M Brida, H Burri, ... European heart journal 44 (39), 3948-4042, 2023 | 354 | 2023 |
| Mechanisms of very late drug-eluting stent thrombosis assessed by optical coherence tomography M Taniwaki, MD Radu, S Zaugg, N Amabile, HM Garcia-Garcia, K Yamaji, ... Circulation 133 (7), 650-660, 2016 | 332 | 2016 |
| Clinical use of intracoronary imaging. Part 2: Acute coronary syndromes, ambiguous coronary angiography findings, and guiding interventional decision-making: An expert … TW Johnson, L Räber, C Di Mario, C Bourantas, H Jia, A Mattesini, ... European heart journal 40 (31), 2566-2584, 2019 | 303 | 2019 |
| Effect of alirocumab added to high-intensity statin therapy on coronary atherosclerosis in patients with acute myocardial infarction: the PACMAN-AMI randomized clinical trial L Räber, Y Ueki, T Otsuka, S Losdat, JD Häner, J Lonborg, G Fahrni, ... Jama 327 (18), 1771-1781, 2022 | 270 | 2022 |
| Risk factors and drug interactions predisposing to statin-induced myopathy: implications for risk assessment, prevention and treatment YS Chatzizisis, KC Koskinas, G Misirli, C Vaklavas, A Hatzitolios, ... Drug safety 33, 171-187, 2010 | 246 | 2010 |
| Natural history of experimental coronary atherosclerosis and vascular remodeling in relation to endothelial shear stress: a serial, in vivo intravascular ultrasound study KC Koskinas, CL Feldman, YS Chatzizisis, AU Coskun, M Jonas, ... Circulation 121 (19), 2092-2101, 2010 | 243 | 2010 |
| Effect of statins and non-statin LDL-lowering medications on cardiovascular outcomes in secondary prevention: a meta-analysis of randomized trials KC Koskinas, GCM Siontis, R Piccolo, D Mavridis, L Räber, F Mach, ... European heart journal 39 (14), 1172-1180, 2018 | 215 | 2018 |
| Evolocumab for early reduction of LDL cholesterol levels in patients with acute coronary syndromes (EVOPACS) KC Koskinas, S Windecker, G Pedrazzini, C Mueller, S Cook, CM Matter, ... Journal of the American College of Cardiology 74 (20), 2452-2462, 2019 | 208 | 2019 |
